×
About 1,148 results

ALLMedicine™ Gastrointestinal Tumors Center

Research & Reviews  551 results

Exosome as potential biomarkers for gastrointestinal tumors.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886441
Medicine Zhang J, Fu S et. al.

Feb 13th, 2021 - Exosomes are polyvesicles that are formed by invagination of intracellular lysosomal particles, and are released into the extracellular matrix after the fusion of polyvesicular outer membrane and cell membrane. In the body, immune response, antige...

Title: pancreatic-type mixed acinar neuroendocrine carcinoma of the stomach: a case rep...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852210
Diagnostic Pathology; Ooe Y, Watanabe K et. al.

Feb 3rd, 2021 - The majority of gastrointestinal tumors are adenocarcinomas. Rarely, there are other types of tumors, such as acinar cell carcinoma, and these are often called pancreatic-type acinar cell carcinomas. Among these tumors, some are differentiated int...

Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointest...
https://doi.org/10.2217/bmm-2020-0359
Biomarkers in Medicine; Flickinger JC, Rappaport JA et. al.

Jan 20th, 2021 - Gastrointestinal cancers encompass a diverse class of tumors arising in the GI tract, including esophagus, stomach, pancreas and colorectum. Collectively, gastrointestinal cancers compose a high fraction of all cancer deaths, highlighting an unmet...

A study of evaluating specific tissue oxygen saturation values of gastrointestinal tumo...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790263
PloS One; Nishihara K, Hori K et. al.

Jan 7th, 2021 - Oxygen saturation (OS) imaging is a new method of endoscopic imaging that has clinical applications in oncology which can directly measure tissue oxygen saturation (Sto2) of the surface of gastrointestinal tract without any additional drugs or dev...

see more →

Guidelines  1 results

Endoscopic resection of superficial gastrointestinal tumors.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977951
World Journal of Gastroenterology; Marc G, Lopes CV

Aug 13th, 2008 - Therapeutic endoscopy plays a major role in the management of gastrointestinal (GI) neoplasia. Its indications can be generalized into four broad categories; to remove or obliterate neoplastic lesion, to palliate malignant obstruction, or to treat...

see more →

Clinicaltrials.gov  581 results

Exosome as potential biomarkers for gastrointestinal tumors.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886441
Medicine Zhang J, Fu S et. al.

Feb 13th, 2021 - Exosomes are polyvesicles that are formed by invagination of intracellular lysosomal particles, and are released into the extracellular matrix after the fusion of polyvesicular outer membrane and cell membrane. In the body, immune response, antige...

Expert Point of View: John C. Krauss, MD
https://ascopost.com/issues/february-10-2021/epov-john-krauss/

Feb 9th, 2021 - The invited discussant of the GARNET study, John C. Krauss, MD, Medical Oncology Director of the Multidisciplinary Colorectal Cancer Clinic, Rogel Cancer Center of the University of Michigan, Ann Arbor, observed that “impressive” response rates to...

Anti–PD-1 Antibody Dostarlimab Active in Mismatch Repair–Deficient Gastrointestinal Tumors
https://ascopost.com/issues/february-10-2021/anti-pd-1-antibody-dostarlimab-active-in-mismatch-repair-deficient-gastrointestinal-tumors/

Feb 9th, 2021 - Dostarlimab, a monoclonal antibody targeting PD-1, showed antitumor activity in patients with mismatch repair–deficient (dMMR) gastrointestinal tumors in the phase I GARNET study, reported at the 2021 Gastrointestinal Cancers Symposium by Thierry ...

Title: pancreatic-type mixed acinar neuroendocrine carcinoma of the stomach: a case rep...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852210
Diagnostic Pathology; Ooe Y, Watanabe K et. al.

Feb 3rd, 2021 - The majority of gastrointestinal tumors are adenocarcinomas. Rarely, there are other types of tumors, such as acinar cell carcinoma, and these are often called pancreatic-type acinar cell carcinomas. Among these tumors, some are differentiated int...

see more →

News  15 results

The March of Immunotherapy Continues at ESMO 2020
https://www.staging.medscape.com/viewarticle/937318

Sep 13th, 2020 - The use of immunotherapy for upper gastrointestinal tumors and renal cancer, ALK- and EGFR-targeted agents in non–small cell lunger cancer (NSCLC), and the next step in personalized prostate cancer management will all be subjects of headlining pre...

The March of Immunotherapy Continues at ESMO 2020
https://www.medscape.com/viewarticle/937318

Sep 13th, 2020 - The use of immunotherapy for upper gastrointestinal tumors and renal cancer, ALK- and EGFR-targeted agents in non–small cell lunger cancer (NSCLC), and the next step in personalized prostate cancer management will all be subjects of headlining pre...

Emerging Platform Technology for Cancer: Nuclear Imaging
https://www.medscape.com/viewarticle/901270

Sep 5th, 2018 - Hello. I'm David Kerr, professor of cancer medicine from University of Oxford. I'm never one not to be self-promoting. That's a gentle joke. Most of you are used to me talking about gastrointestinal tumors, but I wanted to stray into other areas b...

Therapeutic endoscopy expands reach to deep GI lesions
https://www.mdedge.com/gihepnews/article/164086/endoscopy/therapeutic-endoscopy-expands-reach-deep-gi-lesions
Michele G. Sullivan, MDedge News

Apr 24th, 2018 - BOSTON – Endoscopic resection of gastrointestinal tumors arising from the muscularis propria is feasible, but the techniques are challenging and require a sure hand with closure techniques. “The main difficulty with these procedures is closure,” M.

FDA approves Lexicon Pharma's carcinoid syndrome diarrhea drug
https://www.reuters.com/article/us-lexicon-pharm-fda/fda-approves-lexicon-pharmas-carcinoid-syndrome-diarrhea-drug-idUSKBN1672MV

Feb 28th, 2017 - (Reuters) - The U.S. Food and Drug Administration said on Tuesday it had approved Lexicon Pharmaceuticals Inc’s oral drug to treat carcinoid syndrome diarrhea, a condition that develops in patients with gastrointestinal tumors. The drug, Xermelo o...

see more →